A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke


Phase 4 Results N/A

Summary of Purpose

The aim of this study was to confirm the efficacy of piracetam after 12 weeks of treatment on the aphasic status of subjects suffering from aphasia after acute ischemic middle cerebral artery stroke and having received their medication within 7 h post-stroke onset. Trial Stopped: This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 August 2013.

1 Aug 1998 18 Jun 2013 1 Jul 2001 1 Jul 2001 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available